Overview

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.
Phase:
Phase 3
Details
Lead Sponsor:
MEDRx USA, Inc.
Treatments:
Etodolac
Lidocaine